Moreover, if the BF-rTK survived in the tumor via IV administration, it would be assumed that BF-rTK stimulated the production of higher concentrations of cytokines (e.g., IL-1α, IL-1β, IL-2, IL-10, IL-17, GM-CSF, and MCP-1). The gene discussed is CSF2; the disease is neoplasm.